SHPMY OTC
Shanghai Pharmaceuticals Holding Co., Ltd
1W: +10.4%
1M: -2.2%
3M: +0.0%
YTD: -14.0%
1Y: -14.7%
3Y: -7.0%
5Y: -22.5%
$7.08
+0.67 (+10.42%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$221.2B
+4.4% ▲
5Y CAGR: +10.1%
Total Liabilities
$137.5B
+4.4% ▲
5Y CAGR: +9.4%
Shareholders Equity
$71.7B
+4.6% ▲
5Y CAGR: +11.5%
Cash & Investments
$44.4B
+9.1% ▲
5Y CAGR: +19.6%
Total Debt
$47.8B
+11.4% ▲
5Y CAGR: +6.7%
Net Debt
$12.0B
-2.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $22.3B | $22.4B | $27.4B | $30.5B | $35.7B |
| Short-Term Investments | $0 | $0 | $9.6B | $10.2B | $8.6B |
| Cash & ST Investments | $22.3B | $22.4B | $37.0B | $40.7B | $44.4B |
| Net Receivables | $57.5B | $61.0B | $70.2B | $77.2B | $85.3B |
| Inventory | $24.1B | $27.1B | $34.5B | $36.6B | $38.9B |
| Other Current Assets | $5.6B | $6.0B | $7.9B | $8.0B | $1.2B |
| Total Current Assets | $107.6B | $116.5B | $149.5B | $162.4B | $171.8B |
| Property, Plant & Equip. | $14.2B | $15.4B | $16.2B | $18.3B | $19.0B |
| Goodwill & Intangibles | $16.8B | $17.5B | $17.9B | $17.8B | $17.0B |
| Long-Term Investments | $8.9B | $11.8B | $1.9B | $11.1B | $1.2B |
| Other Non-Current Assets | $393M | $857M | $11.1B | $643M | $10.5B |
| Total Non-Current Assets | $41.6B | $46.9B | $48.6B | $49.5B | $49.4B |
| Total Assets | $149.2B | $163.4B | $198.1B | $212.0B | $221.2B |
| — Liabilities — | |||||
| Accounts Payable | $37.8B | $42.0B | $51.6B | $27.8B | $59.5B |
| Short-Term Debt | $29.1B | $23.1B | $27.8B | $35.6B | $38.1B |
| Deferred Revenue | $16.2B | $17.5B | $2.2B | $0 | $0 |
| Other Current Liabilities | $18.7B | $24.0B | $29.1B | $27.4B | $8.6B |
| Total Current Liabilities | $88.1B | $91.8B | $110.7B | $122.4B | $126.0B |
| Long-Term Debt | $1.2B | $7.5B | $6.3B | $5.8B | $8.3B |
| Other Non-Current Liab. | $570M | $290M | -$171M | $289M | $334M |
| Total Non-Current Liabilities | $6.3B | $12.5B | $9.4B | $9.3B | $11.4B |
| Total Liabilities | $94.4B | $104.4B | $120.1B | $131.6B | $137.5B |
| — Equity — | |||||
| Common Stock | $2.8B | $2.8B | $3.7B | $3.7B | $3.7B |
| Retained Earnings | $25.1B | $30.6B | $32.5B | $33.8B | $36.5B |
| Accumulated OCI | -$265M | -$144M | -$371M | $0 | $0 |
| Total Stockholders Equity | $45.4B | $49.4B | $67.1B | $68.5B | $71.7B |
| Total Liabilities & Equity | $149.2B | $163.4B | $198.1B | $212.0B | $221.2B |
| — Key Metrics — | |||||
| Total Debt | $31.8B | $31.7B | $38.6B | $42.9B | $47.8B |
| Net Debt | $9.5B | $9.3B | $11.2B | $12.4B | $12.0B |
| Total Investments | $7.7B | $11.8B | $11.5B | $21.3B | $9.8B |